Navigating geopolitical shifts: India’s strategic position in global pharma supply chains
Rakesh Gupta, Managing Partner, LoEstro Advisors, explains that speed, quality, and transparency will be the key differentiators…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Business Strategies
What the new drug rules mean for quality control in Pharma: From lab to license
Dr Saurabh Arora, Managing Director, Auriga Research, explains how prioritising integrity, infrastructure, digital systems, and…
Reshaping investigations in the pharma industry: Ensuring compliance under the DPDP Act
Sahil Kanuga and Sara Sundaram urge fostering a culture of data protection to ensure that investigations in pharmaceutical and…
Shaping the future of India’s pharmaceutical operations
The McKinsey & Company report analyses India’s pharma landscape, highlighting disruptions, opportunities, and strategic…
Being complacent in pharma quality: Five minutes to midnight
Dr Sumedha Nadkar, Pharma Consultant and Visiting Faculty, shares a hard-hitting article which highlights that complacency in…
Pharma dose CMOs face growth slowdown, but opportunities lie ahead
GlobalData’s expert trend report reveals that the slowdown marks a sharp contrast to the rapid growth seen in 2020-22
Opinion: Flavour encapsulation redefined
Indu Bhushan, CEO and Director - STEERLife highlights the power of hot melt extrusion in food and pharmaceutical applications
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand…
Mankind Pharma transfers OTC biz to subsidiary
Slump sale to be effective on or before October 1, 2024
El Toro Finserve LLP releases 2024 – Healthcare Investment Manifesto for India
Report builds on consumer sentiments and emerging trends to bet on the ideas that will become mainstream or even a unicorn by 2029
GLP1 agonists set to become the best-selling drugs in 2024: GlobalData
Shift could reflect a changing demand away from oncology toward addressing metabolic disorders
Syngene biologics facility to be operational for US, European customers from mid-year
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million…
We are continuing to lead the transformation of the analytical lab
Dr Samir Vyas, Country General Manager, Agilent India speaks on Agilent’s focus areas and growth plans, lessons from the pandemic,…
ISoP launches South Asian Chapter
The initiative will provide a great boost to PV and drug safety not only in India, but the four other South Asian countries namely…
A Superstar marriage?
Chandru Chawla, a pharma veteran, opines that Biocon and SII coming together is a milestone event in the evolution of Indian…
ISPE publishes ISPE APQ Guide: Management Responsibilities and Management Review
This is the second publication in the APQ Guide series that seeks to improve the state of pharmaceutical quality and ensure…
We might need to redefine our approach to drug discovery and approval to be prepared for the future
Hitesh Windlass, MD, Windlas Biotech gives an overview of the changes bought by COVID-19 pandemic in the pharma industry, his…
GenNext at SIRO Clinpharm
SIRO, one of India’s earliest CROs, is set to scale new heights, as its next-gen leaders chart out fresh strategies to sustain its…
HEAL Health Connect Solutions to host e-Summit on Emerging Dimensions in Pharma Excellence
Held in collaboration with Express Pharma, the virtual event will be held on August 20, followed by Pharma Excellence Awards
Our digital-funding-network will support India pharma’s next phase of super-growth
Ravi Tanniru, SVP Enterprise Sales, C2FO India explains C2FO’s concept to Viveka Roychowdhury, and why a high growth industry like…